drugset
drugset / Trial / NCT00965081

A Study for Adult Patients With Fibromyalgia

NCT00965081 ↗

Phase 4 Completed 308 enrolled Eli Lilly and Company
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The main purpose of this study is to determine if 30 milligrams (mg) of duloxetine is effective in the treatment of fibromyalgia compared to placebo.

Timeline

Start
2009-09
Primary completion
2010-11
Completion
2010-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Duloxetine Small molecule 30 mg Oral

Indications

fibromyalgia